previous compound ID: 2660 next compound
InChIKey: XZNUGFQTQHRASN-XQENGBIVSA-N
SMILES: CN[C@H]1[C@H]([C@@H]2[C@H](C[C@H]([C@H](O2)O[C@@H]3[C@H](C[C@H]([C@@H]([C@H]3O)O)N)N)N)O[C@@H]1O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)N)O)O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "SD Macknight" "B Kus" "E Matthes" "D Rotin" "GW Carlile" "R Robert" "DY Thomas" "J Goepp" "J Liao"

chemical graph of compound 2660




CID is 3081545
synonyms found at PubChem are:
apramycin, Nebramycin II, 37321-09-8, Nebramycin factor 2, Apramycinum, Apramicina, Apramycine, UNII-388K3TR36Z, Ambylan, Apralan, CHEBI:2790, 388K3TR36Z, 4-O-((8R)-2-Amino-8-O-(4-amino-4-deoxy-alpha-D-glucopyranosyl)-2,3,7-trideoxy-7-(methylamino)-D-glycero-alpha-D-allo-octodialdo-1,5:8,4-dipyranos-1-yl)-2-deoxy-D-streptamine, 4-O-(3alpha-Amino-6alpha-((4-amino-4-deoxy-alpha-D-glucopyranosyl)oxy)-2,3,4,5abeta,6,7,8,8aalpha-octahydro-8beta-hydroxy-7beta-(methylamino)pyrano(3,2-b)pyran-2alpha-yl)-2-deoxy-D-streptamine, Apramycine [INN-French], Apramycinum [INN-Latin], Apramicina [INN-Spanish], EINECS 253-460-1, EL 857, (2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy}-4-hydroxy-3-(methylamino)octahydropyrano[3,2-b]pyran-2-yl 4-amino-4-deoxy-alpha-D-glucopyranoside, AM2, EL-857/820, Apramycin [USAN:INN:BAN], EL-857, NCGC00016836-01, CAS-37321-09-8, Apramycin (USAN/INN), AC1MIX4B, DSSTox_CID_25465, DSSTox_RID_80896, DSSTox_GSID_45465, SCHEMBL18388, CHEMBL1230961, DTXSID5045465, MolPort-003-983-409, HMS2090I15, D-Streptamine, 4-O-((8R)-2-amino-8-O-(4-amino-4-deoxy-alpha-D-glucopyranosyl)-2,3,7-trideoxy-7-(methylamino)-D-glycero-alpha-D-allo-octodialdo-1,5:8,4-dipyranos-1-yl)-2-deoxy-, ZINC8214486, Tox21_110639, 65710-07-8 (unspecified sulfate), AKOS032944905, API0006565, CS-3070, DB04626, CC-24164, HY-17558, O211, C01555, D02322, AB01275497-01, Apramycin, Antibiotic for Culture Media Use Only, C-23144, W-106548, UNII-NQJ13I4Z9U component XZNUGFQTQHRASN-XQENGBIVSA-N, (2R,3R,4S,5S,6S)-2-[[(2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol, (2R,3R,4S,5S,6S)-5-amino-2-((2R,3S,4R,4aR,6S,7R)-7-amino-6-((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyloxy)-4-hydroxy-3-(methylamino)octahydropyrano[3,2-b]pyran-2-yloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol, D-Streptamine, O-4-amino-4-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.8)-O-(8R)-2-amino-2,3,7-trideoxy-7-(methylamino)-D-glycero-alpha-D-allo-octodialdo-1,5:8,4-dipyranosyl-(1.fwdarw.4)-2-deoxy-, NEBRAMYCIN II, 4-O-(3ALPHA-AMINO-6ALPHA-((4-AMINO-4-DEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY)-2,3,4,5ABETA,6,7,8,8AALPHA-OCTAHYDRO-8BETA-HYDROXY-7BETA-(METHYLAMINO)PYRANO(3,2-B)PYRAN-2ALPHA-YL)-2-DEOXY-D-STREPTAMINE